Medicare Enrolled

Dr. Joseph Sennabaum, M.D.

Hematology · Hudson, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
7651 MEDICAL DR, Hudson, FL 34667
7278689208
In practice since 2006 (20 years)
NPI: 1841261906 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sennabaum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sennabaum? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sennabaum

Dr. Joseph Sennabaum is a hematology in Hudson, FL, with 20 years in practice. Based on federal Medicare data, Dr. Sennabaum performed 93,268 Medicare services across 2,503 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sennabaum received a total of $1,641 from 28 pharmaceutical and/or device companies across 87 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sennabaum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 46% volume in FL$ $1,641 industry payments

Medicare Practice Summary

Medicare Utilization ↗
93,268
Medicare services
Top 46% in FL for hematology
2,503
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,663 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)50,490$0$4
Anti-nausea injection (aprepitant)12,220$1$5
Iron sucrose injection (Venofer)8,000$0$5
Epoetin alfa injection (Procrit) for anemia5,670$6$23
Iron infusion (Monoferric)3,000$17$57
Denosumab injection (Prolia/Xgeva)2,760$18$51
Dexamethasone injection (steroid)1,980$0$3
Complete blood count (CBC) with differential1,609$8$29
Anti-nausea injection (Aloxi/palonosetron)1,200$1$28
Blood draw (venipuncture)1,023$8$9
Drug injection, under skin or into muscle736$10$69
Office visit, established patient (30-39 min)508$96$339
Anti-nausea injection (ondansetron/Zofran)480$0$9
Office visit, established patient (20-29 min)440$64$239
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg426$1$6
Injection of additional new drug or substance into vein337$12$61
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less308$47$189
Administration of chemotherapy into vein, 1 hour or less280$98$378
Injection, zoledronic acid, 1 mg257$7$69
Injection, carboplatin, 50 mg209$2$41
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less204$22$84
Injection, diphenhydramine hcl, up to 50 mg138$1$3
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour127$16$56
Infusion into a vein for hydration, each additional hour94$10$42
Administration of additional new drug or substance into vein, 1 hour or less94$49$178
Red blood count, automated test85$4$10
Administration of chemotherapy into vein, each additional hour82$22$79
Hospital follow-up visit, moderate complexity80$62$197
Infusion, normal saline solution , 1000 cc76$2$7
Administration of additional new drug or substance into vein using push technique57$42$170
Injection of drug or substance into vein42$28$156
Office visit, established patient, complex (40-54 min)40$133$474
Injection, methylprednisolone sodium succinate, up to 40 mg34$3$11
New patient office visit (45-59 min)33$126$453
Initial hospital admission, high complexity31$128$556
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional28$16$59
Automated urinalysis21$2$8
Infusion into a vein for hydration, 31-60 minutes21$25$156
New patient office visit, complex (60-74 min)19$165$585
Initial hospital admission, moderate complexity15$103$377
Red blood count automated, with additional calculations14$5$20
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
58.2% high complexity
37.4% medium
4.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,641
Total received (2018-2024)
Avg $234/year across 7 years
Bottom 20% in FL for hematology
28
Companies
87
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,641 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$430
2023
$325
2022
$439
2021
$269
2020
$69
2019
$76
2018
$33

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$268
Celgene Corporation
$260
PFIZER INC.
$149
Novartis Pharmaceuticals Corporation
$118
GENZYME CORPORATION
$106
Amgen Inc.
$86
Gilead Sciences, Inc.
$84
Astellas Pharma US Inc
$76
Seagen Inc.
$67
ABBVIE INC.
$55
AbbVie Inc.
$38
Karyopharm Therapeutics Inc.
$33
Merck Sharp & Dohme Corporation
$29
Mirati Therapeutics, Inc.
$24
Stemline Therapeutics Inc.
$24
Tempus AI, Inc
$24
Pharmacyclics LLC, An AbbVie Company
$23
Merck Sharp & Dohme LLC
$18
Daiichi Sankyo Inc.
$18
Genentech USA, Inc.
$18
ADC Therapeutics America, Inc.
$17
TG THERAPEUTICS, INC.
$17
Exelixis Inc.
$17
Alnylam Pharmaceuticals Inc.
$16
TAIHO ONCOLOGY, INC.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
GE HealthCare
$14
Secura Bio, Inc.
$9
Top 3 companies account for 41.2% of total payments
Associated products mentioned in payments ›
BOSULIF · Cabometyx · DARZALEX · EPKINLY · Enhertu · Fabhalta · Farydak · GIVLAARI · IBRANCE · IMBRUVICA · Itovebi · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · OPDUALAG · Orserdu · PADCEV · PROMACTA · Pomalyst · REBLOZYL · SARCLISA · SUTENT · TABRECTA · TIVDAK · TUKYSA · Trodelvy · UKONIQ · VENCLEXTA · Vitrakvi · Vyloy · XPOVIO · XT CDX · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a hematology in Hudson?
Compare hematologys in the Hudson area by procedure volume, costs, and industry payment transparency.
Browse hematologys nearby

Geographic Context

Hematologys within 10 mi
19
Per 100K population
3.2
County median income
$67,384
Nearest hospital
HCA FLORIDA BAYONET POINT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sennabaum is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sennabaum experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sennabaum performed 50,490 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sennabaum receive payments from pharmaceutical companies?
Yes. Dr. Sennabaum received a total of $1,641 from 28 companies across 87 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sennabaum's costs compare to other hematologys in Hudson?
Dr. Sennabaum's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sennabaum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →